It was during his doctoral studies at SLU in the field of surgery that Odd Höglund carried out the early development and initial tests of the absorbable implant in the form of a self-locking loop.
SLU Holding Interviews Carl Jonson, a business developer in Alnarp, about an exciting preliminary study of how to extract plant proteins for the food of the future. A method that could in future allow extraction of locally produced sustainable plant proteins, as well as the soy option.
Stefan Roos works part-time as a researcher at SLU, and for four years he has also been employed at BioGaia and has been put in charge of coordinating preclinical research. In 1999 he defended his doctorate through preclinical study of the way the bacterium Lactobacillus reuteri binds to the intestinal mucosa. This was in part to inhibit pathogenic microorganisms and achieve closer interaction with the immunological defence system.
Ilya Pharma is in the middle of an intensive phase involving development and testing of a new way of speeding up wound healing in skin and mucosa. The innovation – the result of several years of collaboration between SLU and Uppsala University – may give rise to a completely new class of biological drugs in which lactobacilli act as small factories producing wound-healing proteins that are applied directly to the wound.
